October 2018—In the Sounding Board section of the fall issue of the AMWA Journal, MPIP Steering Committee members authored their perspectives on the role of medical writers in supporting transparency. The article, titled Medical Writers at the Core of Transparency, is a short piece on the important role that medical writers play in ensuring the development of transparent clinical trial publications.
January 4, 2018—MPIP is now on YouTube. Subscribe to the MPIP YouTube Channel and stay tuned for future videos.
September 22, 2017—MPIP hosted a webinar on the publication, Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective. BMJ. 2016;355:i5078. Presented by co-author Jesse Berlin, ScD, VP and Global Head of Epidemiology, Johnson & Johnson, the webinar gave an insightful overview of the recommendations, which help authors better identify, communicate, and display clinically relevant adverse event information.
August 3, 2017—Do you have a role in transparent data reporting for industry-sponsored research? MPIP has invited society, industry, and publishing experts to share their perspectives on transparent data reporting. The blog posts currently featured provide expert clarification and perspectives on the ICMJE data sharing statement. Stay tuned for new topics throughout 2018!
May 8, 2017—Do you believe that reporting of industry-sponsored research in peer-reviewed journals should be transparent, balanced, and timely? Do you believe that ensuring transparency in medical communications represents an ethical imperative? Let your voice be heard, and tell us what transparency means to you!
November 16, 2016—A new initiative of MPIP designed to raise awareness of the importance of transparency in reporting the results of industry-sponsored research and its impact on credibility. The goal is to broaden the conversation around transparency in medical publications, promote best practices, and engage interested parties in this important mission.
October 11, 2016—EQUATOR highlights MPIP reporting guidelines, noting that the five consensus recommendations supplement the guidance contained in the CONSORT Harms Extension.
October 10, 2016—Knowledgespeak highlights MPIP recommendations to improve adverse event reporting.
October 6, 2016—Clinical Informatics News summarizes MPIP recommendations to improve adverse event reporting.
October 3, 2016—We’ve updated our website with a new look and feel to coincide with the publication of Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective in The BMJ. The website update will make finding information about MPIP and our initiatives much easier, including content devoted to The BMJ article.
October 3, 2016—Recommendations to Improve Adverse Event Reporting in Clinical Trial Publications: A Joint Pharmaceutical Industry/Journal Editor Perspective provides guidance on clinically relevant and more informative adverse event reporting to improve patient care and increase the credibility of industry-sponsored publications published in The BMJ.
October 3, 2016—Follow and visit us on Twitter .
September 6, 2016—MPIP is now on LinkedIn .
April 11, 2016—MPIP authors presented their abstract, Transparency and Credibility of Industry-Sponsored Clinical Trial Publications: A Survey of Journal Editors (CMRO. 2016;32(S1):S13) at the 2016 ISMPP meeting. As part of the poster tour at the meeting, our poster received many reviews and questions from those in attendance.
October 24, 2014—Medical Publishing Insights & Practices (MPIP) Publishes Five‑Step Authorship Framework to Improve Transparency in Disclosing Contributors to Industry-Sponsored Trial Publications.
If members of the media have inquiries for MPIP, please contact us.